Medical Care
Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2024
- Jan 20, 24
- ID: 20478
- Pages: 90
- Figures: 192
- Views: 27
Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation.
The global Circulating Tumor Cell (CTC) Diagnostics market was valued at US$ 7394.8 million in 2023 and is anticipated to reach US$ 20170 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell (CTC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell (CTC) Diagnostics.
Report Scope
The Circulating Tumor Cell (CTC) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cell (CTC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cell (CTC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ApoCell, Inc.(US)
Biocep Ltd. (Israel)
Biocept, Inc.(US)
Biofluidica MicrotechnologiesLLc(US)
Celltraffix Inc.(US)
ClearbridgeBiomedics(Singapore)
Creatv Microtech, Inc.(US)
CynvenioBiosystems, Inc.(US)
EpicBiosciencesInc.(US)
FluxionBiosciences, Inc.(US)
Ikonisys, Inc.(US)
IVDiagnostics, Inc.(US)
JanssenDiagnosticsLLc(US)
QIAGEnHannoverGmbH (Germany)
RARECELLsSAs(Italy)
ScreenCell(France)
STEMCELlTechnologies, Inc.(Canada)
Segment by Type
CTC Enrichment
CTC Detection
Segment by Application
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cell (CTC) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Circulating Tumor Cell (CTC) Diagnostics market was valued at US$ 7394.8 million in 2023 and is anticipated to reach US$ 20170 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell (CTC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell (CTC) Diagnostics.
Report Scope
The Circulating Tumor Cell (CTC) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cell (CTC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cell (CTC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ApoCell, Inc.(US)
Biocep Ltd. (Israel)
Biocept, Inc.(US)
Biofluidica MicrotechnologiesLLc(US)
Celltraffix Inc.(US)
ClearbridgeBiomedics(Singapore)
Creatv Microtech, Inc.(US)
CynvenioBiosystems, Inc.(US)
EpicBiosciencesInc.(US)
FluxionBiosciences, Inc.(US)
Ikonisys, Inc.(US)
IVDiagnostics, Inc.(US)
JanssenDiagnosticsLLc(US)
QIAGEnHannoverGmbH (Germany)
RARECELLsSAs(Italy)
ScreenCell(France)
STEMCELlTechnologies, Inc.(Canada)
Segment by Type
CTC Enrichment
CTC Detection
Segment by Application
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cell (CTC) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and clinics
1.3.3 Pharmaceuticals and biotechnology companies
1.3.4 Academic research institutes
1.3.5 CROs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2019-2030)
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Region
2.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cell (CTC) Diagnostics Market Dynamics
2.3.1 Circulating Tumor Cell (CTC) Diagnostics Industry Trends
2.3.2 Circulating Tumor Cell (CTC) Diagnostics Market Drivers
2.3.3 Circulating Tumor Cell (CTC) Diagnostics Market Challenges
2.3.4 Circulating Tumor Cell (CTC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue
3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023
3.5 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Type
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Application
5.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
6.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
7.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ApoCell, Inc.(US)
11.1.1 ApoCell, Inc.(US) Company Detail
11.1.2 ApoCell, Inc.(US) Business Overview
11.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.1.5 ApoCell, Inc.(US) Recent Development
11.2 Biocep Ltd. (Israel)
11.2.1 Biocep Ltd. (Israel) Company Detail
11.2.2 Biocep Ltd. (Israel) Business Overview
11.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.2.5 Biocep Ltd. (Israel) Recent Development
11.3 Biocept, Inc.(US)
11.3.1 Biocept, Inc.(US) Company Detail
11.3.2 Biocept, Inc.(US) Business Overview
11.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.3.5 Biocept, Inc.(US) Recent Development
11.4 Biofluidica MicrotechnologiesLLc(US)
11.4.1 Biofluidica MicrotechnologiesLLc(US) Company Detail
11.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
11.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
11.5 Celltraffix Inc.(US)
11.5.1 Celltraffix Inc.(US) Company Detail
11.5.2 Celltraffix Inc.(US) Business Overview
11.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.5.5 Celltraffix Inc.(US) Recent Development
11.6 ClearbridgeBiomedics(Singapore)
11.6.1 ClearbridgeBiomedics(Singapore) Company Detail
11.6.2 ClearbridgeBiomedics(Singapore) Business Overview
11.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.6.5 ClearbridgeBiomedics(Singapore) Recent Development
11.7 Creatv Microtech, Inc.(US)
11.7.1 Creatv Microtech, Inc.(US) Company Detail
11.7.2 Creatv Microtech, Inc.(US) Business Overview
11.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.7.5 Creatv Microtech, Inc.(US) Recent Development
11.8 CynvenioBiosystems, Inc.(US)
11.8.1 CynvenioBiosystems, Inc.(US) Company Detail
11.8.2 CynvenioBiosystems, Inc.(US) Business Overview
11.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.8.5 CynvenioBiosystems, Inc.(US) Recent Development
11.9 EpicBiosciencesInc.(US)
11.9.1 EpicBiosciencesInc.(US) Company Detail
11.9.2 EpicBiosciencesInc.(US) Business Overview
11.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.9.5 EpicBiosciencesInc.(US) Recent Development
11.10 FluxionBiosciences, Inc.(US)
11.10.1 FluxionBiosciences, Inc.(US) Company Detail
11.10.2 FluxionBiosciences, Inc.(US) Business Overview
11.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.10.5 FluxionBiosciences, Inc.(US) Recent Development
11.11 Ikonisys, Inc.(US)
11.11.1 Ikonisys, Inc.(US) Company Detail
11.11.2 Ikonisys, Inc.(US) Business Overview
11.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.11.5 Ikonisys, Inc.(US) Recent Development
11.12 IVDiagnostics, Inc.(US)
11.12.1 IVDiagnostics, Inc.(US) Company Detail
11.12.2 IVDiagnostics, Inc.(US) Business Overview
11.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.12.5 IVDiagnostics, Inc.(US) Recent Development
11.13 JanssenDiagnosticsLLc(US)
11.13.1 JanssenDiagnosticsLLc(US) Company Detail
11.13.2 JanssenDiagnosticsLLc(US) Business Overview
11.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.13.5 JanssenDiagnosticsLLc(US) Recent Development
11.14 QIAGEnHannoverGmbH (Germany)
11.14.1 QIAGEnHannoverGmbH (Germany) Company Detail
11.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
11.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
11.15 RARECELLsSAs(Italy)
11.15.1 RARECELLsSAs(Italy) Company Detail
11.15.2 RARECELLsSAs(Italy) Business Overview
11.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.15.5 RARECELLsSAs(Italy) Recent Development
11.16 ScreenCell(France)
11.16.1 ScreenCell(France) Company Detail
11.16.2 ScreenCell(France) Business Overview
11.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.16.5 ScreenCell(France) Recent Development
11.17 STEMCELlTechnologies, Inc.(Canada)
11.17.1 STEMCELlTechnologies, Inc.(Canada) Company Detail
11.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
11.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and clinics
1.3.3 Pharmaceuticals and biotechnology companies
1.3.4 Academic research institutes
1.3.5 CROs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2019-2030)
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Region
2.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cell (CTC) Diagnostics Market Dynamics
2.3.1 Circulating Tumor Cell (CTC) Diagnostics Industry Trends
2.3.2 Circulating Tumor Cell (CTC) Diagnostics Market Drivers
2.3.3 Circulating Tumor Cell (CTC) Diagnostics Market Challenges
2.3.4 Circulating Tumor Cell (CTC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue
3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023
3.5 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Type
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Application
5.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
6.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
7.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ApoCell, Inc.(US)
11.1.1 ApoCell, Inc.(US) Company Detail
11.1.2 ApoCell, Inc.(US) Business Overview
11.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.1.5 ApoCell, Inc.(US) Recent Development
11.2 Biocep Ltd. (Israel)
11.2.1 Biocep Ltd. (Israel) Company Detail
11.2.2 Biocep Ltd. (Israel) Business Overview
11.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.2.5 Biocep Ltd. (Israel) Recent Development
11.3 Biocept, Inc.(US)
11.3.1 Biocept, Inc.(US) Company Detail
11.3.2 Biocept, Inc.(US) Business Overview
11.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.3.5 Biocept, Inc.(US) Recent Development
11.4 Biofluidica MicrotechnologiesLLc(US)
11.4.1 Biofluidica MicrotechnologiesLLc(US) Company Detail
11.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
11.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
11.5 Celltraffix Inc.(US)
11.5.1 Celltraffix Inc.(US) Company Detail
11.5.2 Celltraffix Inc.(US) Business Overview
11.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.5.5 Celltraffix Inc.(US) Recent Development
11.6 ClearbridgeBiomedics(Singapore)
11.6.1 ClearbridgeBiomedics(Singapore) Company Detail
11.6.2 ClearbridgeBiomedics(Singapore) Business Overview
11.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.6.5 ClearbridgeBiomedics(Singapore) Recent Development
11.7 Creatv Microtech, Inc.(US)
11.7.1 Creatv Microtech, Inc.(US) Company Detail
11.7.2 Creatv Microtech, Inc.(US) Business Overview
11.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.7.5 Creatv Microtech, Inc.(US) Recent Development
11.8 CynvenioBiosystems, Inc.(US)
11.8.1 CynvenioBiosystems, Inc.(US) Company Detail
11.8.2 CynvenioBiosystems, Inc.(US) Business Overview
11.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.8.5 CynvenioBiosystems, Inc.(US) Recent Development
11.9 EpicBiosciencesInc.(US)
11.9.1 EpicBiosciencesInc.(US) Company Detail
11.9.2 EpicBiosciencesInc.(US) Business Overview
11.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.9.5 EpicBiosciencesInc.(US) Recent Development
11.10 FluxionBiosciences, Inc.(US)
11.10.1 FluxionBiosciences, Inc.(US) Company Detail
11.10.2 FluxionBiosciences, Inc.(US) Business Overview
11.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.10.5 FluxionBiosciences, Inc.(US) Recent Development
11.11 Ikonisys, Inc.(US)
11.11.1 Ikonisys, Inc.(US) Company Detail
11.11.2 Ikonisys, Inc.(US) Business Overview
11.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.11.5 Ikonisys, Inc.(US) Recent Development
11.12 IVDiagnostics, Inc.(US)
11.12.1 IVDiagnostics, Inc.(US) Company Detail
11.12.2 IVDiagnostics, Inc.(US) Business Overview
11.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.12.5 IVDiagnostics, Inc.(US) Recent Development
11.13 JanssenDiagnosticsLLc(US)
11.13.1 JanssenDiagnosticsLLc(US) Company Detail
11.13.2 JanssenDiagnosticsLLc(US) Business Overview
11.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.13.5 JanssenDiagnosticsLLc(US) Recent Development
11.14 QIAGEnHannoverGmbH (Germany)
11.14.1 QIAGEnHannoverGmbH (Germany) Company Detail
11.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
11.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
11.15 RARECELLsSAs(Italy)
11.15.1 RARECELLsSAs(Italy) Company Detail
11.15.2 RARECELLsSAs(Italy) Business Overview
11.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.15.5 RARECELLsSAs(Italy) Recent Development
11.16 ScreenCell(France)
11.16.1 ScreenCell(France) Company Detail
11.16.2 ScreenCell(France) Business Overview
11.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.16.5 ScreenCell(France) Recent Development
11.17 STEMCELlTechnologies, Inc.(Canada)
11.17.1 STEMCELlTechnologies, Inc.(Canada) Company Detail
11.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
11.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2019-2024)
Table 8. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2025-2030)
Table 10. Circulating Tumor Cell (CTC) Diagnostics Market Trends
Table 11. Circulating Tumor Cell (CTC) Diagnostics Market Drivers
Table 12. Circulating Tumor Cell (CTC) Diagnostics Market Challenges
Table 13. Circulating Tumor Cell (CTC) Diagnostics Market Restraints
Table 14. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2023)
Table 17. Ranking of Global Top Circulating Tumor Cell (CTC) Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
Table 21. Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. ApoCell, Inc.(US) Company Detail
Table 47. ApoCell, Inc.(US) Business Overview
Table 48. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 49. ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 50. ApoCell, Inc.(US) Recent Development
Table 51. Biocep Ltd. (Israel) Company Detail
Table 52. Biocep Ltd. (Israel) Business Overview
Table 53. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product
Table 54. Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Biocep Ltd. (Israel) Recent Development
Table 56. Biocept, Inc.(US) Company Detail
Table 57. Biocept, Inc.(US) Business Overview
Table 58. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 59. Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Biocept, Inc.(US) Recent Development
Table 61. Biofluidica MicrotechnologiesLLc(US) Company Detail
Table 62. Biofluidica MicrotechnologiesLLc(US) Business Overview
Table 63. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 64. Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Biofluidica MicrotechnologiesLLc(US) Recent Development
Table 66. Celltraffix Inc.(US) Company Detail
Table 67. Celltraffix Inc.(US) Business Overview
Table 68. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 69. Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Celltraffix Inc.(US) Recent Development
Table 71. ClearbridgeBiomedics(Singapore) Company Detail
Table 72. ClearbridgeBiomedics(Singapore) Business Overview
Table 73. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product
Table 74. ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 75. ClearbridgeBiomedics(Singapore) Recent Development
Table 76. Creatv Microtech, Inc.(US) Company Detail
Table 77. Creatv Microtech, Inc.(US) Business Overview
Table 78. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 79. Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Creatv Microtech, Inc.(US) Recent Development
Table 81. CynvenioBiosystems, Inc.(US) Company Detail
Table 82. CynvenioBiosystems, Inc.(US) Business Overview
Table 83. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 84. CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 85. CynvenioBiosystems, Inc.(US) Recent Development
Table 86. EpicBiosciencesInc.(US) Company Detail
Table 87. EpicBiosciencesInc.(US) Business Overview
Table 88. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 89. EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 90. EpicBiosciencesInc.(US) Recent Development
Table 91. FluxionBiosciences, Inc.(US) Company Detail
Table 92. FluxionBiosciences, Inc.(US) Business Overview
Table 93. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 94. FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 95. FluxionBiosciences, Inc.(US) Recent Development
Table 96. Ikonisys, Inc.(US) Company Detail
Table 97. Ikonisys, Inc.(US) Business Overview
Table 98. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 99. Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 100. Ikonisys, Inc.(US) Recent Development
Table 101. IVDiagnostics, Inc.(US) Company Detail
Table 102. IVDiagnostics, Inc.(US) Business Overview
Table 103. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 104. IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 105. IVDiagnostics, Inc.(US) Recent Development
Table 106. JanssenDiagnosticsLLc(US) Company Detail
Table 107. JanssenDiagnosticsLLc(US) Business Overview
Table 108. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 109. JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 110. JanssenDiagnosticsLLc(US) Recent Development
Table 111. QIAGEnHannoverGmbH (Germany) Company Detail
Table 112. QIAGEnHannoverGmbH (Germany) Business Overview
Table 113. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product
Table 114. QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 115. QIAGEnHannoverGmbH (Germany) Recent Development
Table 116. RARECELLsSAs(Italy) Company Detail
Table 117. RARECELLsSAs(Italy) Business Overview
Table 118. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product
Table 119. RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 120. RARECELLsSAs(Italy) Recent Development
Table 121. ScreenCell(France) Company Detail
Table 122. ScreenCell(France) Business Overview
Table 123. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product
Table 124. ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 125. ScreenCell(France) Recent Development
Table 126. STEMCELlTechnologies, Inc.(Canada) Company Detail
Table 127. STEMCELlTechnologies, Inc.(Canada) Business Overview
Table 128. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product
Table 129. STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 130. STEMCELlTechnologies, Inc.(Canada) Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. CTC Enrichment Features
Figure 4. CTC Detection Features
Figure 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Hospitals and clinics Case Studies
Figure 8. Pharmaceuticals and biotechnology companies Case Studies
Figure 9. Academic research institutes Case Studies
Figure 10. CROs Case Studies
Figure 11. Circulating Tumor Cell (CTC) Diagnostics Report Years Considered
Figure 12. Global Circulating Tumor Cell (CTC) Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Circulating Tumor Cell (CTC) Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Region: 2023 VS 2030
Figure 15. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players in 2023
Figure 16. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023
Figure 18. North America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 20. United States Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 24. Germany Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2019-2030)
Figure 32. China Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 40. Mexico Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 44. Turkey Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. ApoCell, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 47. Biocep Ltd. (Israel) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 48. Biocept, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 49. Biofluidica MicrotechnologiesLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 50. Celltraffix Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 51. ClearbridgeBiomedics(Singapore) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 52. Creatv Microtech, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 53. CynvenioBiosystems, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 54. EpicBiosciencesInc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 55. FluxionBiosciences, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 56. Ikonisys, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 57. IVDiagnostics, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 58. JanssenDiagnosticsLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 59. QIAGEnHannoverGmbH (Germany) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 60. RARECELLsSAs(Italy) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 61. ScreenCell(France) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 62. STEMCELlTechnologies, Inc.(Canada) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2019-2024)
Table 8. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2025-2030)
Table 10. Circulating Tumor Cell (CTC) Diagnostics Market Trends
Table 11. Circulating Tumor Cell (CTC) Diagnostics Market Drivers
Table 12. Circulating Tumor Cell (CTC) Diagnostics Market Challenges
Table 13. Circulating Tumor Cell (CTC) Diagnostics Market Restraints
Table 14. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2023)
Table 17. Ranking of Global Top Circulating Tumor Cell (CTC) Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
Table 21. Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. ApoCell, Inc.(US) Company Detail
Table 47. ApoCell, Inc.(US) Business Overview
Table 48. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 49. ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 50. ApoCell, Inc.(US) Recent Development
Table 51. Biocep Ltd. (Israel) Company Detail
Table 52. Biocep Ltd. (Israel) Business Overview
Table 53. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product
Table 54. Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Biocep Ltd. (Israel) Recent Development
Table 56. Biocept, Inc.(US) Company Detail
Table 57. Biocept, Inc.(US) Business Overview
Table 58. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 59. Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Biocept, Inc.(US) Recent Development
Table 61. Biofluidica MicrotechnologiesLLc(US) Company Detail
Table 62. Biofluidica MicrotechnologiesLLc(US) Business Overview
Table 63. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 64. Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Biofluidica MicrotechnologiesLLc(US) Recent Development
Table 66. Celltraffix Inc.(US) Company Detail
Table 67. Celltraffix Inc.(US) Business Overview
Table 68. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 69. Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Celltraffix Inc.(US) Recent Development
Table 71. ClearbridgeBiomedics(Singapore) Company Detail
Table 72. ClearbridgeBiomedics(Singapore) Business Overview
Table 73. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product
Table 74. ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 75. ClearbridgeBiomedics(Singapore) Recent Development
Table 76. Creatv Microtech, Inc.(US) Company Detail
Table 77. Creatv Microtech, Inc.(US) Business Overview
Table 78. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 79. Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Creatv Microtech, Inc.(US) Recent Development
Table 81. CynvenioBiosystems, Inc.(US) Company Detail
Table 82. CynvenioBiosystems, Inc.(US) Business Overview
Table 83. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 84. CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 85. CynvenioBiosystems, Inc.(US) Recent Development
Table 86. EpicBiosciencesInc.(US) Company Detail
Table 87. EpicBiosciencesInc.(US) Business Overview
Table 88. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 89. EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 90. EpicBiosciencesInc.(US) Recent Development
Table 91. FluxionBiosciences, Inc.(US) Company Detail
Table 92. FluxionBiosciences, Inc.(US) Business Overview
Table 93. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 94. FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 95. FluxionBiosciences, Inc.(US) Recent Development
Table 96. Ikonisys, Inc.(US) Company Detail
Table 97. Ikonisys, Inc.(US) Business Overview
Table 98. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 99. Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 100. Ikonisys, Inc.(US) Recent Development
Table 101. IVDiagnostics, Inc.(US) Company Detail
Table 102. IVDiagnostics, Inc.(US) Business Overview
Table 103. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 104. IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 105. IVDiagnostics, Inc.(US) Recent Development
Table 106. JanssenDiagnosticsLLc(US) Company Detail
Table 107. JanssenDiagnosticsLLc(US) Business Overview
Table 108. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 109. JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 110. JanssenDiagnosticsLLc(US) Recent Development
Table 111. QIAGEnHannoverGmbH (Germany) Company Detail
Table 112. QIAGEnHannoverGmbH (Germany) Business Overview
Table 113. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product
Table 114. QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 115. QIAGEnHannoverGmbH (Germany) Recent Development
Table 116. RARECELLsSAs(Italy) Company Detail
Table 117. RARECELLsSAs(Italy) Business Overview
Table 118. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product
Table 119. RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 120. RARECELLsSAs(Italy) Recent Development
Table 121. ScreenCell(France) Company Detail
Table 122. ScreenCell(France) Business Overview
Table 123. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product
Table 124. ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 125. ScreenCell(France) Recent Development
Table 126. STEMCELlTechnologies, Inc.(Canada) Company Detail
Table 127. STEMCELlTechnologies, Inc.(Canada) Business Overview
Table 128. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product
Table 129. STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024) & (US$ Million)
Table 130. STEMCELlTechnologies, Inc.(Canada) Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. CTC Enrichment Features
Figure 4. CTC Detection Features
Figure 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Hospitals and clinics Case Studies
Figure 8. Pharmaceuticals and biotechnology companies Case Studies
Figure 9. Academic research institutes Case Studies
Figure 10. CROs Case Studies
Figure 11. Circulating Tumor Cell (CTC) Diagnostics Report Years Considered
Figure 12. Global Circulating Tumor Cell (CTC) Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Circulating Tumor Cell (CTC) Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Region: 2023 VS 2030
Figure 15. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players in 2023
Figure 16. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023
Figure 18. North America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 20. United States Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 24. Germany Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2019-2030)
Figure 32. China Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 40. Mexico Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2019-2030)
Figure 44. Turkey Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. ApoCell, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 47. Biocep Ltd. (Israel) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 48. Biocept, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 49. Biofluidica MicrotechnologiesLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 50. Celltraffix Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 51. ClearbridgeBiomedics(Singapore) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 52. Creatv Microtech, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 53. CynvenioBiosystems, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 54. EpicBiosciencesInc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 55. FluxionBiosciences, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 56. Ikonisys, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 57. IVDiagnostics, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 58. JanssenDiagnosticsLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 59. QIAGEnHannoverGmbH (Germany) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 60. RARECELLsSAs(Italy) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 61. ScreenCell(France) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 62. STEMCELlTechnologies, Inc.(Canada) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232